IndraLab

Statements


3 | 1 1

reach
"Moreover, USP34, as a deubiquitinase, could interact with SOX2, and reduce the polyubiquitination of SOX2."

sparser
"Moreover, in cisplatin-resistant laryngeal squamous cell carcinoma (LSCC) cells, USP34’s interaction with SOX2, a key CSC- and EMT-related transcription factor, decreases SOX2 polyubiquitination and augments LSCC cell sensitivity to cisplatin [ xref ] (Fig. xref A)."

No evidence text available

No evidence text available

No evidence text available